Evolutionary variation of papillomavirus E2 protein and E2 binding sites

Virology Journal

Volumn 8, Issue , 2011, Pages

  Rogers, Adam ^a   Waltke, MacKenzie ^a   Angeletti, Peter C ^a  

^a UNIVERSITY OF NEBRASKA   (United States)

Author keywords

DNA binding Domain; E2 Protein; extrachromosomal DNA; Human papillomavirus; persistent infection

Indexed keywords

NUCLEOTIDE; PAPILLOMA VIRUS E2 PROTEIN; REGULATOR PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN; DNA BINDING PROTEIN; ONCOGENE PROTEIN E2, HUMAN PAPILLOMAVIRUS TYPE 1; ONCOPROTEIN; VIRUS DNA;

ALPHAPAPILLOMAVIRUS; AMINO ACID SEQUENCE; ARTICLE; BETAPAPILLOMAVIRUS; BINDING SITE; DELTAPAPILLOMAVIRUS; GAMMAPAPILLOMAVIRUS; LAMBDAPAPILLOMAVIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PAPILLOMA VIRUS; PAPILLOMA VIRUS E2 PROTEIN BINDING SITE; PHYLOGENETIC TREE; VIRUS GENOME; XIPAPILLOMAVIRUS; ANIMAL; CLUSTER ANALYSIS; DNA BASE COMPOSITION; GENETICS; HUMAN; MOLECULAR EVOLUTION; PHYLOGENY; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY;

HUMAN PAPILLOMAVIRUS; PAPILLOMAVIRIDAE;

ANIMALS; BASE COMPOSITION; BINDING SITES; CLUSTER ANALYSIS; DNA, VIRAL; DNA-BINDING PROTEINS; EVOLUTION, MOLECULAR; HUMANS; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; PHYLOGENY; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 79960861304     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-8-379     Document Type: Article

References (42)

1. Papillomavirus genome structure, expression, and post-transcriptional regulation. Zheng ZM, Baker CC, Front Biosci 2006 11 2286 2302 10.2741/1971 16720315 (Pubitemid 43822560)
2. Papillomaviruses infect cells via a clathrin-dependent pathway. Day PM, Lowy DR, Schiller JT, Virology 2003 307 1 11 10.1016/S0042-6822(02)00143-5 12667809 (Pubitemid 36355861)
3. Papillomavirus Research: From Natural History to Vaccines and Beyond. Bosch FX, Sanjose S, Castellsague X, Moreno V, Munoz N, Wymondham: Caisreir Academic Press, Saveria Campo M, 2006 19 40
4. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Clifford GM, Smith JS, Plummer M, Munoz N, Franceschi S, Br J Cancer 2003 88 63 73 10.1038/sj.bjc.6600688 12556961 (Pubitemid 36241220)
5. Epidemiologic classification of human papillomavirus types associated with cervical cancer. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, Snijders PJ, Meijer CJ, N Engl J Med 2003 348 518 527 10.1056/NEJMoa021641 12571259 (Pubitemid 36159887)
6. Case-Control Study of Human Papillomavirus and Oropharyngeal Cancer. D'Souza G, Kreimer AR, Viscidi R, Pawlita M, Fakhry C, Koch WM, Westra WH, Gillison ML, N Engl J Med 2007 356 1944 1956 10.1056/NEJMoa065497 17494927 (Pubitemid 46740304)
7. Classification of papillomaviruses. de Villiers E-M, Fauquet C, Broker TR, Bernard H-U, zur Hausen H, Virology 2004 324 17 27 10.1016/j.virol.2004.03. 033 15183049 (Pubitemid 38737395)
8. The papillomavirus E2 proteins: structure, function, and biology. Hegde RS, Annu Rev Biophys Biomol Struct 2002 31 343 360 10.1146/annurev.biophys.31. 100901.142129 11988474 (Pubitemid 34666837)
9. Classification of papillomaviruses. de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H, Virology 2004 324 17 27 10.1016/j.virol.2004.03.033 15183049 (Pubitemid 38737395)
10. Systematic review of genomic integration sites of human papillomavirus genomes in epithelial dysplasia and invasive cancer of the female lower genital tract. Wentzensen N, Vinokurova S, von Knebel Doeberitz M, Cancer Res 2004 64 3878 3884 10.1158/0008-5472.CAN-04-0009 15172997 (Pubitemid 38697299)
11. The papillomavirus E2 regulatory proteins. McBride AA, Romanczuk H, Howley PM, J Biol Chem 1991 266 18411 18414 1655748 (Pubitemid 21908095)
12. Targeted mutagenesis of the human papillomavirus type 16 E2 transactivation domain reveals separable transcriptional activation and DNA replication functions. Sakai H, Yasugi T, Benson JD, Dowhanick JJ, Howley PM, J Virol 1996 70 1602 1611 8627680 (Pubitemid 26062919)
13. Structure of the intact transactivation domain of the human papillomavirus E2 protein. Antson AA, Burns JE, Moroz OV, Scott DJ, Sanders CM, Bronstein IB, Dodson GG, Wilson KS, Maitland NJ, Nature 2000 403 805 809 10.1038/35001638 10693813 (Pubitemid 30111845)
14. CpG methylation directly inhibits binding of the human papillomavirus type 16 E2 protein to specific DNA sequences. Thain A, Jenkins O, Clarke A, Gaston K, J Virol 1996 70 7233 7235 8794373 (Pubitemid 26307443)
15. Free Energy Contributions to Direct Readout of a DNA Sequence. Ferriero DU, Delarole M, Nadra AD, De Prat Gay G, J Biol Chem 2005 32480 32484 (Pubitemid 41361860)
16. Indirect Readout of DNA Sequence by Papillomavirus E2 Proteins Depends Upon Net Cation Uptake. Blakaj DM, Kattamuri C, Khrapunov S, Hegde RS, Brenowitz M, J Mol Biol 2006 358 224 240 10.1016/j.jmb.2006.01.093 16513133
17. Comparison of the Structure and DNA-binding Properties of the E2 Proteins from an Oncogenic and a Non-oncogenic Human Papillomavirus. Dell G, Wilkinson KW, Tranter R, Parish J, Leo Brady R, Gaston K, J Mol Biol 2003 334 979 991 10.1016/j.jmb.2003.10.009 14643661 (Pubitemid 37485684)
18. DNA structure and flexibility in the sequence-specific binding of papillomavirus E2 proteins. Hines CS, Meghoo C, Shetty S, Biburger M, Brenowitz M, Hegde RS, J Mol Biol 1998 276 809 818 10.1006/jmbi.1997.1578 9500925 (Pubitemid 28122291)
19. Specific recognition nucleotides and their DNA context determine the affinity of E2 protein for 17 binding sites in the BPV-1 genome. Li R, Knight J, Bream G, Stenlund A, Botchan M, Genes & Development 1989 510 526 21809467
20. Comprehensive comparison of the interaction of the E2 master regulator with its cognate target DNA sites in 73 human papillomavirus types by sequence statistics. Sanchez IE, Dellarole M, Gaston K, de Prat Gay G, Nucl Acids Res 2008 36 756 769 18084026 (Pubitemid 351267233)
21. Predicting indirect readout effects in protein-DNA interactions. Yongli Zhang, Zhiqun Xi, Rashmi S Hegde, Zippora Shakked, Crothers aDM, PNAS 2004 101 8337 8341 10.1073/pnas.0402319101 15148366 (Pubitemid 38736576)
22. The E2 binding sites determine the efficiency of replication for the origin of human papillomavirus type 18. M Remm RB, Jenkins JR, Nucleic Acids Res 1992 20 6015 6021 10.1093/nar/20.22.6015 1334259
23. Dose-dependent regulation of the early promoter of human papillomavirus type 18 by the viral E2 protein. Corbach GSaS, J Virol 1997 71 50 58 8985322
24. Epidermodysplasia verruciformis associated human papilomaviruses present a subgenus-specific organization of the regulatory genome region. Ensser A, Pfister H, Nucl Acids Res 1990 18 3919 3922 10.1093/nar/18.13.3919 2165253
25. Cis and trans requirements for stable episomal maintenance of the BPV-1 replicator. Piirsoo M, Ustav E, Mandel T, Stenlund A, Ustav M, Embo J 1996 15 1 11 8598191 (Pubitemid 26020383)
26. Differential requirements for conserved E2 binding sites in the life cycle of oncogenic human papillomavirus type 31. Stubenrauch F, Lim HB, Laimins LA, J Virol 1998 72 1071 1077 9445001 (Pubitemid 28116886)
27. Two E2 binding sites alone are sufficient to function as the minimal origin of replication of human papillomavirus type 18 DNA. Sverdrup F, Khan SA, J Virol 1995 69 1319 1323 7815514
28. Specific recognition nucleotides and their DNA context determine the affinity of E2 protein for 17 binding sites in the BPV-1 genome. Li R, Knight J, Bream G, Stenlund A, Botchan M, Genes & Development 1989 3 510 526 10.1101/gad.3.4.510 21809467
29. Fitting a mixture model by expectation maximization to discover motifs in biopolymers. Bailey TL, Elkan C, Proceedings of the Second International Conference on Intelligent Systems for Molecular Biology Menlo Park, California: AAAI Press 1994 28 36
30. Chapter 17, The Reference Sequence (RefSeq) Project. The NCBI handbook Bethesda: National Library of Medicine (US), National Center for Biotechnology Information 2002
31. A common language for physical mapping of the human genome. Olson M HL, Cantor C, Botstein D, Science 1989 245 1434 1435 10.1126/science.2781285 2781285
32. NCBI Reference Sequence (RefSeq): a curated non-redundant sequence database of genomes, transcripts and proteins. Pruitt KDT, T Maglott DR, Nucleic Acids Res 2007 35 Database 61 35 10.1093/nar/gkl842 17130148 (Pubitemid 46056171)
33. Combining evidence using p-values: application to sequence homology searches. Bailey TL, Gribskov M, Bioinformatics 1998 14 48 54 10.1093/bioinformatics/14.1.48 9520501 (Pubitemid 28395676)
34. MUSCLE: multiple sequence alignment with high accuracy and high throughput. Edgar RC, Nucleic Acids Res 2004 32 1792 1797 10.1093/nar/gkh340 15034147 (Pubitemid 38832724)
35. COBALT: constraint-based alignment tool for multiple protein sequences. Papadopoulos JS, Agarwala R, Bioinformatics 2007 23 1073 1079 10.1093/bioinformatics/btm076 17332019 (Pubitemid 47050558)
36. Overlapping reading frames in closely related human papillomaviruses result in modular rates of selection within E2. Narechania A, Terai M, Burk RD, J Gen Virol 2005 86 1307 1313 10.1099/vir.0.80747-0 15831941 (Pubitemid 40613247)
37. DNA bending by asymmetric phosphate neutralization. Strauss JK, Maher LJ, Science 1994 266 1829 1834 10.1126/science.7997878 7997878
38. The transcription activation domains of Fos and Jun induce DNA bending through electrostatic interactions. Kerppola TK, Curran T, Embo J 1997 16 2907 2916 10.1093/emboj/16.10.2907 9184234 (Pubitemid 27226226)
39. Specific recognition nucleotides and their DNA context determine the affinity of E2 protein for 17 binding sites in the BPV-1 genome. Li R, Knight J, Bream G, Stenlund A, Botchan M, Genes Dev 1989 3 510 526 10.1101/gad.3.4.510 2542129
40. Transcriptional activation of the human papillomavirus type 5 and 16 long control region in cells from cutaneous and mucosal origin. Mistry N, Simonsson M, Evander M, Virol J 2007 4 27 10.1186/1743-422X-4-27 17352804 (Pubitemid 46434562)
41. Many different papillomaviruses have low transcriptional activity in spite of strong epithelial specific enhancers. Sailaja G, Watts RM, Bernard HU, J Gen Virol 1999 80 Pt 7 1715 1724 10423140 (Pubitemid 29319863)
42. Brd4 Is Required for E2-Mediated Transcriptional Activation but Not Genome Partitioning of All Papillomaviruses. McPhillips MG, Oliveira JG, Spindler JE, Mitra R, McBride AA, J Virol 2006 80 9530 9543 10.1128/JVI.01105-06 16973557 (Pubitemid 44435629)